Jacob Leach S.'s most recent trade in SenesTech Inc was a trade of 100,000 Stock Option (right to buy) done . Disclosure was reported to the exchange on June 15, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| SenesTech Inc | Jacob S. Leach | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jun 2026 | 100,000 | 100,000 | - | - | Stock Option (right to buy) | |
| DexCom | Jacob S. Leach | Director, President, CEO, and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 71.90 per share. | 22 May 2026 | 1,451 | 420,359 (0%) | 0% | 71.9 | 104,327 | Common Stock |
| DexCom | Jacob S. Leach | Director, President, CEO, and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2026 | 104,516 | 441,567 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob S. Leach | Director, President, CEO, and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 68.10 per share. | 08 Mar 2026 | 19,757 | 421,810 (0%) | 0% | 68.1 | 1,345,452 | Common Stock |
| DexCom | Jacob S. Leach | Director, President, CEO, and Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 29 Jan 2026 | 8,310 | 340,109 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob S. Leach | Director, President, CEO, and Director | Payment of exercise price or tax liability using portion of securities received from the company at price $ 73.36 per share. | 29 Jan 2026 | 3,058 | 337,051 (0%) | 0% | 73.4 | 224,335 | Common Stock |
| SenesTech Inc | Jacob S. Leach | Director | Sale of securities on an exchange or to another person at price $ 2.71 per share. | 18 Nov 2025 | 62 | 0 (0%) | 0% | 2.7 | 168 | Common Stock |
| DexCom | Jacob S. Leach | President & COO | Purchase of securities on an exchange or from another person at price $ 54.98 per share. | 10 Nov 2025 | 15,700 | 329,197 (0%) | 0% | 55.0 | 863,139 | Common Stock |
| DexCom | Jacob S. Leach | President & COO | Purchase of securities on an exchange or from another person at price $ 55.43 per share. | 10 Nov 2025 | 2,500 | 331,697 (0%) | 0% | 55.4 | 138,563 | Common Stock |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 70.38 per share. | 12 Mar 2025 | 14,076 | 313,497 (0%) | 0% | 70.4 | 990,670 | Common Stock |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 35,906 | 304,775 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 08 Mar 2025 | 22,798 | 327,573 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 28 Jan 2025 | 7,107 | 271,278 (0%) | 0% | 0 | Common Stock | |
| DexCom | Jacob Leach S. | EVP, Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 86.91 per share. | 28 Jan 2025 | 2,634 | 268,644 (0%) | 0% | 86.9 | 228,932 | Common Stock |